Israel cấp phép thuốc Molnupiravir của Merck, cho phép tiêm liều 4

Bộ Y tế Israel ngày 2/1 thông báo đã cấp phép sử dụng thuốc điều trị COVID-19 do tập đoàn dược phẩm đa quốc gia Merck của Mỹ sản xuất, sau quyết định tương tự đối với thuốc Paxlovid của Pfizer.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh